Skip to main content

Akebia Therapeutics, Inc 10-Q for FY2025 Q3

Akebia Therapeutics, Inc. (AKBA)

10-Q 2025-11-10 For: 2025-09-30
View Original
Added on April 11, 2026

About this 10-Q

Akebia Therapeutics, Inc filed this 10-Q on November 10, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).

Headline figures

Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$58.77M
up 57.0% from $37.43M a year earlier
Net income
$540K
compared with a net loss of $20.04M a year earlier
Diluted EPS
$0.00
compared with -$0.10 a year earlier